These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 17761118)
1. Optimal use of diuretics in patients with heart failure. Patel J; Smith M; Heywood JT Curr Treat Options Cardiovasc Med; 2007 Aug; 9(4):332-42. PubMed ID: 17761118 [TBL] [Abstract][Full Text] [Related]
2. [Value of aldosterone receptor blockade in diuretic therapy of patients with chronic heart failure]. Christ M; Ludwig N; Maisch B Herz; 2002 Mar; 27(2):135-49. PubMed ID: 12025459 [TBL] [Abstract][Full Text] [Related]
3. Rationale and Design of the "Safety and Efficacy of the Combination of Loop with Thiazide-type Diuretics in Patients with Decompensated Heart Failure (CLOROTIC) Trial:" A Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of Combined Diuretic Therapy (Loop Diuretics With Thiazide-Type Diuretics) Among Patients With Decompensated Heart Failure. Trullàs JC; Morales-Rull JL; Casado J; Freitas Ramírez A; Manzano L; Formiga F; J Card Fail; 2016 Jul; 22(7):529-36. PubMed ID: 26576715 [TBL] [Abstract][Full Text] [Related]
4. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial. Gattis WA; O'Connor CM; Gallup DS; Hasselblad V; Gheorghiade M; J Am Coll Cardiol; 2004 May; 43(9):1534-41. PubMed ID: 15120808 [TBL] [Abstract][Full Text] [Related]
5. Metabolic and toxicological considerations for diuretic therapy in patients with acute heart failure. Aspromonte N; Cruz DN; Valle R; Bonello M; Tubaro M; Gambaro G; Marchese G; Santini M; Ronco C Expert Opin Drug Metab Toxicol; 2011 Sep; 7(9):1049-63. PubMed ID: 21599566 [TBL] [Abstract][Full Text] [Related]
10. Practical applications of intravenous diuretic therapy in decompensated heart failure. Cleland JG; Coletta A; Witte K Am J Med; 2006 Dec; 119(12 Suppl 1):S26-36. PubMed ID: 17113397 [TBL] [Abstract][Full Text] [Related]
11. Effective use of loop diuretics in heart failure exacerbation: a nephrologist's view. Sambandam KK Am J Med Sci; 2014 Feb; 347(2):139-45. PubMed ID: 23588260 [TBL] [Abstract][Full Text] [Related]
16. American College of Cardiology/American Heart Association Chronic Heart Failure Evaluation and Management guidelines: relevance to the geriatric practice. Ahmed A J Am Geriatr Soc; 2003 Jan; 51(1):123-6. PubMed ID: 12534856 [TBL] [Abstract][Full Text] [Related]
17. Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure. Johnson W; Omland T; Hall C; Lucas C; Myking OL; Collins C; Pfeffer M; Rouleau JL; Stevenson LW J Am Coll Cardiol; 2002 May; 39(10):1623-9. PubMed ID: 12020489 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological and Non-pharmacological Strategies for Volume Overload in Acute Decompensated Congestive Heart Failure: A Review Article. Zafar MR; Miller TW; Mustafa SF; Al-Khafaji N Cureus; 2020 Feb; 12(2):e6952. PubMed ID: 32190502 [TBL] [Abstract][Full Text] [Related]
19. Diuretic use in heart failure and outcomes. von Lueder TG; Atar D; Krum H Clin Pharmacol Ther; 2013 Oct; 94(4):490-8. PubMed ID: 23852396 [TBL] [Abstract][Full Text] [Related]
20. Determinants and impact of the natriuretic response to diuretic therapy in heart failure with reduced ejection fraction and volume overload. Verbrugge FH; Dupont M; Bertrand PB; Nijst P; Penders J; Dens J; Verhaert D; Vandervoort P; Tang WH; Mullens W Acta Cardiol; 2015 Jun; 70(3):265-73. PubMed ID: 26226699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]